Microbial Vesicles Show Great Promise in Vaccine Development

Microbial outer membrane vesicles are a growing tool in the introduction of vaccine as well as behave as therapeutic and drug delivery agents, reveals new research.

Outer membrane vesicles, biological nanoparticles shed during normal growth by bacteria, have experienced significant recent advances in engineering and therefore are thus finding new utility as therapeutic and drug delivery agents.

‘Bacterial vesicles can be used something in vaccine development as well as drug-delivery agents.’

Just one research focus explored lately within the literature is using microbial vesicles as adjuvants in vaccine formulations.

Early success in this region has shown protection against infection by a few microbial species in animal models by engineering vesicles to show species-specific antigens as cargo, either inside the interior from the vesicles or displayed on the outside of vesicle surface.

In order to highlight recent advances in this subject, this short article explores recent and continuing efforts to build up novel engineering methods targeted at supplying new functionalities for microbial vesicles because they affect vaccine formulations.

Particularly emerging technologies for engineering these structures, including cargo loading and surface modification is going to be explored. Microbial vesicles show great promise as biologically, derived nanoparticles that may be the platform technology in a number of fields.

With ongoing growth and development of novel engineering tools, as well as an elevated understanding within their biogenesis and biological fate in living systems there’s significant possibility to develop microbial vesicles as tools because of not only vaccine development but in addition for use within the delivery of therapeutic compounds to targeted cells.

Source: Eurekalert

Leave a Reply

Your email address will not be published. Required fields are marked *